Burning Rock Biotech
BNR
#9406
Rank
NZ$64.73 M
Marketcap
$6.31
Share price
3.93%
Change (1 day)
-60.53%
Change (1 year)

Revenue for Burning Rock Biotech (BNR)

Revenue in 2024 (TTM): NZ$0.11 Billion

According to Burning Rock Biotech's latest financial reports the company's current revenue (TTM ) is NZ$0.12 Billion. In 2023 the company made a revenue of NZ$0.11 Billion a decrease over the revenue in the year 2022 that were of NZ$0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Burning Rock Biotech from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.11 B-2.81%
2023 NZ$0.11 B-8.49%
2022 NZ$0.13 B13.88%
2021 NZ$0.11 B31.89%
2020 NZ$87.26 M6.52%
2019 NZ$81.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$3.35 M-97.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.07 B 784.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.68 B 17,807.96%๐Ÿ‡บ๐Ÿ‡ธ USA